Actively Recruiting
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Led by Cambridge Health Alliance · Updated on 2026-02-19
20
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot study aims to explore the potential benefits of consuming Greek bottarga (grey mullet fish roe) in individuals with at least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes. Before initiating the crossover randomized controlled trial (RCT), the investigators will conduct a preliminary dose-testing study in five adults with at least one metabolic abnormality. Participants will undergo clinical assessments before and after the dietary intervention to evaluate changes in metabolic health markers. Following this phase, the investigators will proceed with a randomized, controlled crossover trial involving 20 eligible adult participants. This main study phase will compare the metabolic effects of daily bottarga supplementation with those of a calorically matched dairy product over an 8-week intervention period, with a 2-week washout period between interventions. The investigators anticipate that bottarga supplementation will improve lipid profiles, inflammation markers, and insulin resistance, thereby supporting the potential use of sustainable blue foods as part of a healthy diet.
CONDITIONS
Official Title
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-60 years
- Residents of Massachusetts
- Have at least one metabolic abnormality (low HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, obesity, or HbA1c 65 5.7%) or a diagnosis of diabetes
- Not pregnant
- Willing to consume a nutritional supplement and follow study procedures
You will not qualify if you...
- Use of medications for diabetes (except metformin), dyslipidemia (except statins), or immunosuppression
- Taking supplements containing n-3 fatty acids
- Current use of illicit drugs (other than marijuana)
- Use of hormone therapy (except oral contraceptives)
- Known allergies to fish, seafood, or fish-derived products including bottarga
- Pregnancy
- History or clinical evidence of liver or kidney problems
- Having immunodeficiency conditions
- History of non-skin cancer
- Currently participating in other clinical research studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cambridge Health Alliance
Sommerville, Massachusetts, United States, 02145
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here